The association between smoking cessation outpatient visits and total medical costs: a retrospective, observational analysis of Japanese employee-based public health insurance data

References

• Ministry of Health Labour and Welfare. National Health and Nutrition Examination Survey [Internet]. Tokyo, Japan: Ministry of Health Labour and Welfare; 2014. Available at: http://www.mhlw.go.jp/file/04-Houdouhappyou-10904750-Kenkoukyoku-Gantaisakukenkouzoushinka/0000117311.pdf [Japanese]
   Google Scholar
• WHO. World Health Statistics 2016: Monitoring health for the SDGs [Internet]. Geneva, Switzerland: World Health Organization; 2016. Available at: http://www.who.int/gho/publications/world_health_statistics/2016/en/
   Google Scholar
• Institute for Health Economics and Policy. Research on smoking cessation policy “Cost Estimation of Spending” report. Tokyo, Japan: Institute for Health Economics and Policy; 2010
   Google Scholar
• Izumi Y, Tsuji I, Ohkubo T, et al. Impact of smoking habit on medical care use and its costs: a prospective observation of National Health Insurance beneficiaries in Japan. Int J Epidemiol 2001;30:616-23
   PubMed Web of Science ®Google Scholar
• Ministry of Health Labour and Welfare. Health Japan 21: National Health Promotion in the 21st Century [Internet]. Tokyo, Japan: Ministry of Health Labour and Welfare; 2012. Available at: http://www.mhlw.go.jp/file/06-Seisakujouhou-10900000-Kenkoukyoku/0000047330.pdf
   Google Scholar
• Japanese Circulation Society. Clinical practice guidelines for smoking cessation pharmacotherapy and counseling, sixth edition [Internet]. Tokyo, Japan: Japanese Circulation Society; 2014. Available at: http://www.j-circ.or.jp/kinen/anti_smoke_std/pdf/anti_smoke_std_rev6.pdf [Japanese]
   Google Scholar
• Nakamura M. Health insurance coverage for smoking cessation treatment in Japan: current status and future issues. Nihon Rinsho Jap J Clin Med 2013;71:499-505 [Japanese]
   PubMedGoogle Scholar
• Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev 2005;2:CD001292
   Google Scholar
• Stead LF, Lancaster T. Behavioural interventions as adjuncts to pharmacotherapy for smoking cessation. Cochrane Database Syst Rev 2012;12:CD009670 [Database]
   PubMedGoogle Scholar
• Hartmann-Boyce J, Stead LF, Cahill K, et al. Efficacy of interventions to combat tobacco addiction: Cochrane update of 2013 reviews. Addiction 2014;109:1414-25
   PubMed Web of Science ®Google Scholar
• Nakamura K, Sakurai M, Miura K, et al. Nicotine dependence and cost-effectiveness of individualized support for smoking cessation: evidence from practice at a worksite in Japan. PLoS One 2013;8:e55836
   PubMed Web of Science ®Google Scholar
• Stead LF, Buitrago D, Preciado N, et al. Physician advice for smoking cessation. Cochrane Database Syst Rev 2013;5:CD000165
   PubMed Web of Science ®Google Scholar
• Igarashi A, Takuma H, Fukuda T, et al. Cost-utility analysis of varenicline, an oral smoking-cessation drug, in Japan. Pharmacoeconomics 2009;27:247-61
   PubMed Web of Science ®Google Scholar
• Igarashi A, Goto R, Suwa K, et al. Cost-effectiveness analysis of smoking cessation interventions in Japan using a discrete-event simulation. Appl Health Econ Health Policy 2016;14:77-87
   PubMed Web of Science ®Google Scholar
• International Agency for Research on Cancer. Tobacco control: Reversal of risk after quitting smoking. IARC Hbk Cancer Prevent 2007;11:11
   Google Scholar
• Menzin J, Lines LM, Marton J. Estimating the short-term clinical and economic benefits of smoking cessation: do we have it right? Expert Rev Pharmacoecon Outcomes Res 2009;9:257-64
   PubMedGoogle Scholar
• Ministry of Health, Labour and Welfare. Statistical classification of diseases and cause of death [Internet]. Tokyo, Japan: Ministry of Health, Labour and Welfare; 2013. Available at: http://www.mhlw.go.jp/toukei/sippei/ [Japanese]
   Google Scholar
• Tsuji I. Study of economic impact of smoking cessation - Analysis of healthcare cost and cost-effectiveness, Research Grant of MHLW in Japan [Internet]. 2010. Available at: http://mhlw-grants.niph.go.jp/niph/search/NIDD00.do?resrchNum=201021049A [Japanese]
   Google Scholar
• Theadom A, Cropley M. Effects of preoperative smoking cessation on the incidence and risk of intraoperative and postoperative complications in adult smokers: a systematic review. Tob Control 2006;15:352-8
   PubMed Web of Science ®Google Scholar
• Ministry of Health Labour and Welfare. Estimates of National medical care expenditure, FY 2013, summary of results [Internet]. Tokyo: Ministry of Health Labour and Welfare; 2013. Available at: http://www.mhlw.go.jp/toukei/saikin/hw/k-iryohi/13/dl/kekka.pdf [Japanese]
   Google Scholar
• Nakagawa M, Tanaka H, Tsukuma H, et al. Relationship between the duration of the preoperative smoke-free period and the incidence of postoperative pulmonary complications after pulmonary surgery. Chest 2001;120:705-10
   PubMed Web of Science ®Google Scholar
• Grønkjaer M, Eliasen M, Skov-Ettrup LS, et al. Preoperative smoking status and postoperative complications: a systematic review and meta-analysis. Ann Surg 2014;259:52-71
   PubMed Web of Science ®Google Scholar
• Böckerman P, Hyytinen A, Kaprio J. Smoking and long-term labour market outcomes. Tob Control 2015;24:348-53
   PubMed Web of Science ®Google Scholar
• Central Social Insurance Medical Council. Special survey for verification of revision of medical treatment fees 2009 [Internet]. Tokyo: Ministry of Health Labour and Welfare; 2010. Available at: http://www.mhlw.go.jp/shingi/2010/06/dl/s0602-3i.pdf [Japanese]
   Google Scholar
• Annual Health, Labor and Welfare Report 2013–2014 [Internet]. Tokyo, Japan: Ministry of Health Labour and Welfare; 2014. Available at: http://www.mhlw.go.jp/wp/hakusyo/kousei/14-2/dl/02.pdf [Japanese]
   Google Scholar
• Fujihara K, Igarashi R, Yamamoto M, et al. Impact of glucose tolerance status on the development of coronary artery disease among working-age men. Diabetes Metab 2017;43:261-4
   PubMed Web of Science ®Google Scholar
• Miwa H, Takeshima T, Iwasaki K, et al. Medical cost, incidence rate, and treatment status of gastroesophageal reflux disease in Japan: analysis of claims data. J Med Econ 2016;19:1049-55
   Google Scholar
• Kurtyka K, Nishikino R, Ito C, et al. Adherence to dipeptidyl peptidase-4 inhibitor therapy among type 2 diabetes patients with employer-sponsored health insurance in Japan. J Diabetes Investig 2016;7:737-43
   PubMed Web of Science ®Google Scholar
• Tanihara S, Tsuji M, Kawazoe M, et al. Comparison of the number of claims per population in each large classification of disease. J Health Welfare Stat 2017;64 [Japanese]
   Google Scholar